ObjectiveExaminations of Patient-Reported Outcomes Measurement Information System (PROMIS) measures in adult systemic lupus erythematosus (SLE) have provided support for their cross-sectional validity in SLE. We estimated responsiveness to change, meaningful changes (minimally important differences [MIDs]), and the patient acceptable symptom state (PASS) for five PROMIS short forms to facilitate longitudinal use and interpretation of PROMIS scales in SLE.MethodsData from five administrations of PROMIS short forms in the FORWARD SLE cohorts were used. Pearson correlation coefficients were used to assess associations between changes in PROMIS measures and changes in anchor measures for responsiveness analyses. Worse, same, or better groups we...
The onset of rheumatic disease affects each patient differently and may impact quality of life with ...
Objective. To determine whether quality of life in patients with systemic lupus erythematosus (SLE) ...
Objective. Improved standards for the evaluation of therapeutic interventions in systemic lupus eryt...
Objectives: Patient-reported outcome measures (PROMs) are evaluated in randomized controlled trials ...
BackgroundThe evaluation of Patient Reported Outcomes Measurement Information System (PROMIS) comput...
IF 2.454International audienceObjective The lupus impact tracker (LIT) is a 10-item patient reported...
Inclusion of patient-reported outcomes is important in SLE clinical trials as they allow capture of ...
Background: Accurate measurement of patient reported outcomes (PROs) is crucial to understanding how...
Abstract Background Comprehensive assessment of systemic lupus erythematosus (SLE) and its treatment...
Abstract Objective To account for heterogeneity in systemic lupus erythematosus (SLE) and bridge dis...
Measuring lupus disease activity accurately remains a challenging and demanding task given the compl...
ABSTRACT. Objective. The aims of this study were to assess the construct validity and the test-retes...
Jamal Mikdashi Division of Rheumatology and Clinical Immunology, University of Maryland School of Me...
Objectives. This study aimed to estimate the responsiveness to change of a generic [the 36-item Shor...
Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder that has detrimental effects on ...
The onset of rheumatic disease affects each patient differently and may impact quality of life with ...
Objective. To determine whether quality of life in patients with systemic lupus erythematosus (SLE) ...
Objective. Improved standards for the evaluation of therapeutic interventions in systemic lupus eryt...
Objectives: Patient-reported outcome measures (PROMs) are evaluated in randomized controlled trials ...
BackgroundThe evaluation of Patient Reported Outcomes Measurement Information System (PROMIS) comput...
IF 2.454International audienceObjective The lupus impact tracker (LIT) is a 10-item patient reported...
Inclusion of patient-reported outcomes is important in SLE clinical trials as they allow capture of ...
Background: Accurate measurement of patient reported outcomes (PROs) is crucial to understanding how...
Abstract Background Comprehensive assessment of systemic lupus erythematosus (SLE) and its treatment...
Abstract Objective To account for heterogeneity in systemic lupus erythematosus (SLE) and bridge dis...
Measuring lupus disease activity accurately remains a challenging and demanding task given the compl...
ABSTRACT. Objective. The aims of this study were to assess the construct validity and the test-retes...
Jamal Mikdashi Division of Rheumatology and Clinical Immunology, University of Maryland School of Me...
Objectives. This study aimed to estimate the responsiveness to change of a generic [the 36-item Shor...
Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder that has detrimental effects on ...
The onset of rheumatic disease affects each patient differently and may impact quality of life with ...
Objective. To determine whether quality of life in patients with systemic lupus erythematosus (SLE) ...
Objective. Improved standards for the evaluation of therapeutic interventions in systemic lupus eryt...